- Home
- DTE vs BNTX Comparison
DTE vs BNTX Comparison
Compare DTE & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTE
- BNTX
- Stock Information
- Founded
- DTE 1903
- BNTX 2008
- Country
- DTE United States
- BNTX Germany
- Employees
- DTE N/A
- BNTX N/A
- Industry
- DTE Electric Utilities: Central
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DTE Utilities
- BNTX Health Care
- Exchange
- DTE Nasdaq
- BNTX Nasdaq
- Market Cap
- DTE 26.1B
- BNTX 23.9B
- IPO Year
- DTE N/A
- BNTX 2019
- Fundamental
- Price
- DTE $121.09
- BNTX $113.77
- Analyst Decision
- DTE Buy
- BNTX Strong Buy
- Analyst Count
- DTE 16
- BNTX 15
- Target Price
- DTE $131.38
- BNTX $143.50
- AVG Volume (30 Days)
- DTE 1.3M
- BNTX 630.9K
- Earning Date
- DTE 02-06-2025
- BNTX 11-04-2024
- Dividend Yield
- DTE 3.60%
- BNTX N/A
- EPS Growth
- DTE 21.85
- BNTX N/A
- EPS
- DTE 7.38
- BNTX N/A
- Revenue
- DTE $12,415,000,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- DTE $2.48
- BNTX N/A
- Revenue Next Year
- DTE $2.50
- BNTX N/A
- P/E Ratio
- DTE $16.41
- BNTX N/A
- Revenue Growth
- DTE N/A
- BNTX N/A
- 52 Week Low
- DTE $102.17
- BNTX $76.53
- 52 Week High
- DTE $131.67
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- DTE 48.25
- BNTX 48.60
- Support Level
- DTE $116.65
- BNTX $109.52
- Resistance Level
- DTE $120.49
- BNTX $115.34
- Average True Range (ATR)
- DTE 2.02
- BNTX 4.35
- MACD
- DTE 0.01
- BNTX -0.72
- Stochastic Oscillator
- DTE 69.08
- BNTX 26.76
About DTE DTE Energy Company
DTE Energy owns two regulated utilities in Michigan that contribute 90% of earnings. DTE Electric serves approximately 2.3 million customers in southeastern Michigan, including Detroit. DTE Gas serves 1.3 million customers throughout the state. In addition, DTE has nonutility businesses and investments including energy marketing and trading, renewable natural gas facilities, and on-site industrial energy projects.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.